A Pharma ETF Focused On Quality, Fast-Growing Stocks

Otmane El Rhazi from Investor's Business Daily - ETFs RSS.

Drugmakers delivered tasty returns to investors in July. Pharmaceutical ETFs topped peers holding broadly diversified health care stocks as well as those focused on red-hot biotechs. (PJP) lags its pharma ETF peers this month despite a 3.6% rise. But it leads year to date with a 22% advance, and over longer periods. It produced an annual average 35% gain over five years vs. 30% for (XPH). The $2.14 billion ETF holds several IBD Sector Leaders in